Researchers from the UK used integrated genomics to analyze prospectively collected samples from metastatic clear cell renal cell carcinoma patients.

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.

The Cambridge, UK-based single-cell analysis firm will use the funding to expand its R&D and international sales activities, as well as to improve customer support.

The tests could be used to make treatment and management decisions, and inform on epidemiologic trends or new and emerging viruses.

The FDA's Database for Reference Grade Microbial Sequences is a publicly available collection of sequenced microbes, including biothreat organisms.

The findings do not support any of the three theories previously suggested for the genetic origins of the Tarim Basin population, the researchers reported.

Using an approach tailored to low-coverage ancient DNA data and distant relationships, researchers confirmed family ties between the leader and his great-grandson.